Evidence map›Paper›PMID 29330300›Full record

ArticleThe Journal of biological chemistry2018

Real-time imaging of yeast cells reveals several distinct mechanisms of curing of the [URE3] prion.

Xiaohong Zhao, Jenna Lanz, Danielle Steinberg, Tyler Pease, Joseph M Ahearn, Evgeny E Bezsonov, Elena D Staguhn, Evan Eisenberg, Daniel C Masison, Lois E Greene

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Differential Interactions of Molecular Chaperones and Yeast Prions.Journal of fungi (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Article
  11. Mechanisms for Curing Yeast Prions.International journal of molecular sciences · 2020
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xiaohong ZhaoFrom the Laboratory of Cell Biology, NHLBI and.
Jenna LanzFrom the Laboratory of Cell Biology, NHLBI and.
Danielle SteinbergFrom the Laboratory of Cell Biology, NHLBI and.
Tyler PeaseFrom the Laboratory of Cell Biology, NHLBI and.
Joseph M AhearnFrom the Laboratory of Cell Biology, NHLBI and.
Evgeny E Bezsonovthe Laboratory of Biochemistry and Genetics, NIDDK, National Institutes of Health, Bethesda, Maryland 20892-0301.
Elena D StaguhnFrom the Laboratory of Cell Biology, NHLBI and.
Evan EisenbergFrom the Laboratory of Cell Biology, NHLBI and.
Daniel C Masisonthe Laboratory of Biochemistry and Genetics, NIDDK, National Institutes of Health, Bethesda, Maryland 20892-0301.
Lois E GreeneFrom the Laboratory of Cell Biology, NHLBI and greenel@helix.nih.gov.
National Institutes of Health · USNational Heart Lung and Blood Institute · US

Funding

Role of molecular chaperones in protein folding diseasesZIAHL000516 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GREENE, LOIS · 2009 to 2022
$19.6M
70 KD Heat Shock and their associated cofactorsZ01HL000516 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI GREENE, LOIS · 1987 to 2008
$4.0M
Chaperone-amyloid interactionsZIADK024954 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI MASISON, DANIEL · 2009 to 2025
$3.8M
Intramural NIH HHS Z01 HL000516
6 · The paper itself

Abstract

The [URE3] yeast prion is the self-propagating amyloid form of the Ure2 protein. [URE3] is cured by overexpression of several yeast proteins, including Ydj1, Btn2, Cur1, Hsp42, and human DnaJB6. To better understand [URE3] curing, we used real-time imaging with a yeast strain expressing a GFP-labeled full-length Ure2 construct to monitor the curing of [URE3] over time. [URE3] yeast cells exhibited numerous fluorescent foci, and expression of the GFP-labeled Ure2 affected neither mitotic stability of [URE3] nor the rate of [URE3] curing by the curing proteins. Using guanidine to cure [URE3] via Hsp104 inactivation, we found that the fluorescent foci are progressively lost as the cells divide until they are cured; the fraction of cells that retained the foci was equivalent to the [URE3] cell fraction measured by a plating assay, indicating that the foci were the prion seeds. During the curing of [URE3] by Btn2, Cur1, Hsp42, or Ydj1 overexpression, the foci formed aggregates, many of which were 0.5 μm or greater in size, and [URE3] was cured by asymmetric segregation of the aggregated seeds. In contrast, DnaJB6 overexpression first caused a loss of detectable foci in cells that were still [URE3] before there was complete dissolution of the seeds, and the cells were cured. We conclude that GFP labeling of full-length Ure2 enables differentiation among the different [URE3]-curing mechanisms, including inhibition of severing followed by seed dilution, seed clumping followed by asymmetric segregation between mother and daughter cells, and seed dissolution.

Indexed as

Molecular ImagingFungal ProteinsPrionsTime FactorsYeastsFungal ProteinsPrionsamyloidmolecular chaperoneprionprotein foldingyeast

Identifiers

PMID29330300
PMCPMC5836123
OpenAlexW2783976796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.